Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LETM1P1 is a pseudogene in humans, annotated as "leucine zipper-EF-hand containing transmembrane protein 1 pseudogene 1." Pseudogenes are DNA segments that resemble functional genes but carry disabling mutations preventing expression of functional proteins. The parent gene, LETM1, encodes an inner mitochondrial membrane protein involved in calcium/proton exchange, but LETM1P1 does not produce a functional product and is generally considered an "evolutionary relic". Current evidence does not support LETM1P1 having a therapeutic role or being a direct disease modifier. In some cases, pseudogenes may have regulatory effects (e.g., as microRNA decoys), but such a function is not established for LETM1P1. In summary: LETM1P1 is a non-coding pseudogene and not a therapeutic target, receptor, or functional protein; the entry is incorrect as a druggable target since it does not produce an active molecule.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine zipper-EF-hand containing transmembrane protein 1 pseudogene 1 (LETM1P1).